Unlock instant, AI-driven research and patent intelligence for your innovation.

Detection of GDF-8 modulating agents

A technology for GDF-8 and regulators, which is applied to the detection of exogenous GDF-8 regulators in biological samples and the detection of GDF-8 inhibitors in biological samples, which can solve the disadvantages of cumbersome GDF-8 regulators, introduction, and direct detection And other issues

Inactive Publication Date: 2008-03-19
WYETH LLC
View PDF23 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However direct detection is disadvantageous as such methods may be cumbersome and may result in the introduction of potentially dangerous or toxic substances to the individual to whom the GDF-8 modulator is administered (US Patent No. 2004 / 0142382-A1 )

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection of GDF-8 modulating agents

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0199] To detect MYO-029 in human serum, an ELISA assay was performed as follows. First, add streptavidin coating solution (100 μL / well) (5 μg / mL immunopurified streptavidin (Pierce) in 0.1M carbonate / bicarbonate buffer, pH 9.6) to absorb streptavidin. Parafilm-covered plates were incubated overnight at 2-8°C. Using an automatic plate washer, wash with THST buffer (300 μL / well) (50 mM Tris-HCl, pH 8.0, containing 1.0 mM glycine, 0.5 M NaCl and 0.05% (v / v) Tween 20  (J.T. Baker)) wash the plate four times and invert the plate after the second wash. For blocking, 200 μL of blocking buffer (1% bovine serum (Sigma), 0.02% sodium azide in PBS (Dulbeccos)) was added to each well. Cover the plate with parafilm and incubate at room temperature for 1-2 hours, then wash as above. Add biotinylated GDF-8 solution (biotin:GDF-8 molar ratio between 0:1 and 3:1) (100 μL / well) (0.5 μg / mL in THST in the buffer). The plate was sealed and incubated with a shaker at room temperature for 2 ...

Embodiment 2

[0215] Dilution linearity: The dilution linearity of the method was evaluated by analyzing human serum samples spiked with MYO-029 in 11 different dilutions. Samples at 54000 ng / ml were first diluted 8-fold in THST buffer + 4% skim milk powder, and then serially diluted (1:2) in THST + 4% skim milk powder + 10% normal human serum. The dilution is intended to drop the concentration above, within or below the assay range. The dilution bias was determined to be between -9.7% and -0.4% for samples within the quantitative range of the assay. No trend of bias was found. The observed decrease in concentration was as expected and there was no evidence of a prozone effect.

[0216] Specificity: Incorporation / recovery experiments were performed using 10 different batches of human serum (individual donors) at MYO-029 incorporation concentrations of 0, 135, and 540 ng / mL to study potential incorporation from the sample matrix (or matrix effect). non-specific interference. Endogenous m...

Embodiment 3

[0226] Biotinylated GDF-8 was as follows. Expression of full-length GDF-8 in fed-batch CHO cell culture bioreactor processing provides potential complex forms of GDF-8. Cell culture harvests were clarified using normal flow microfiltration followed by concentration and diafiltration using tangential flow ultrafiltration. The retained mixture was then loaded onto the Ni that captures the GDF-8 complex 2+ - NTA-immobilized metal affinity chromatography (IMAC). with 50mM Na 2 HPO 4 , 300mM NaCl, 20-500mM imidazole for linear gradient elution over 5 column volumes. The resulting peak was then buffer exchanged by dialysis to remove the imidazole from the IMAC and replace it with the appropriate buffer for the biotinylation reaction.

[0227] The potential complex preparation is then biotinylated. The molecular molar ratio of target sulfo-NHS-LC-biotin and GDF-8 complex used in this reaction was 14:1. For example, reagent to substrate ratios of 10:1, 15:1 and 20:1 were also t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides methods for detecting GDF-8 modulators in animals, including humans, including methods for detecting the presence of exogenous GDF-8 modulators, such as GDF-8 inhibitors, in a biological sample. In particular, methods of assessing the presence and / or amount of a GDF-8 modulator in a biological sample are provided.

Description

[0001] related case [0002] This application claims priority to US Provisional Application No. 60 / 664,400, filed March 23, 2005, the contents of which are incorporated by reference in their entirety. Background of the invention [0003] Growth and differentiation factor-8 (GDF-8), also known as myostatin, is a secreted protein that is a negative regulator of skeletal muscle mass. Inhibitors of GDF-8 promote muscle growth and may be beneficial in the treatment of many conditions including sarcopenia, cachexia and muscular dystrophy. [0004] GDF-8 is a member of the transforming growth factor beta (TGF-beta) superfamily of structurally related growth factors. Members of this superfamily possess physiologically important functions of growth regulation and morphogenesis (Kingsley et al., Genes Dev.8:133-146 (1994); Hoodless et al., Curr.TopicsMicrobiol.Immunol.228:235-272( 1998)). Likewise, they share a common structural composition, including a short peptide signal for secre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68
CPCG01N33/74G01N2500/00A61P21/00A61P43/00
Inventor J·A·诺瓦克J·G·克莱恩K·F·默里J·W·拉杰维斯基三世S·孙N·M·沃夫曼
Owner WYETH LLC